Rheumatoid arthritis market and epidemiology forecast 2024-2034 featuring analysis of ati-450 (aclaris therapeutics) and olumiant/baricitinib (eli lilly/incyte)

Dublin, june 25, 2024 (globe newswire) -- the "rheumatoid arthritis market: epidemiology, industry trends, share, size, growth, opportunity, and forecast 2024-2034" report has been added to researchandmarkets.com's offering. the 7 major rheumatoid arthritis markets reached a value of us$ 27.5 billion in 2023. looking forward, the 7mm are projected to reach us$ 33.8 billion by 2034, exhibiting a growth rate (cagr) of 2.32% during 2023-2034.
ACRS Ratings Summary
ACRS Quant Ranking